Osteoarthritis arises from breakdown of cartilage covering bone joints, which leads to chronic inflammation, and current therapies provide only short-term relief with risk of side effects. In an effort to identify next-generation treatments, researchers at Chang Gung University and Chang Gung Memorial Hospital have identified a potential novel therapeutic target, platelet-derived growth factor receptor-like protein (PDGFRL).